Position in NVS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,188,908
+$122,354 QoQ
Shares Held
13,967
+3.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#406
of 1,603 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fort Sheridan Advisors LLC holds $58,603,256 across 10 Drug Manufacturers - General names. NVS ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
68,432 | $17,220,228 | |
| 2 | JNJ |
Johnson & Johnson
|
50,589 | $12,848,088 | |
| 3 | MRK |
Merck & Co., Inc.
|
98,070 | $12,601,995 | |
| 4 | LLY |
ELI LILLY & Co
|
5,314 | $6,373,771 | |
| 5 | AMGN |
Amgen Inc
|
8,505 | $3,079,830 | |
| 6 | PFE |
Pfizer Inc
|
120,987 | $2,913,366 | |
| 7 | NVS |
Novartis AG
This page
|
13,967 | $2,188,908 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,810 | $607,695 |
All Filings in NVS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,188,908 | 13,967 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,066,554 | 13,529 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,365,602 | 9,905 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,083,115 | 8,446 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $971,347 | 8,027 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $894,849 | 8,027 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $780,718 | 8,023 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $922,805 | 8,023 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $868,607 | 8,159 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $789,220 | 8,159 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $809,173 | 8,014 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $815,694 | 8,008 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $743,000 | 7,363 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $515,844 | 5,607 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $510,027 | 5,622 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $427,328 | 5,622 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $477,340 | 5,647 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $495,524 | 5,647 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $509,687 | 5,827 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $476,532 | 5,827 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $536,947 | 5,885 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $273,194 | 3,196 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||